Progyny, Inc. (PGNY)

NASDAQ: PGNY · USD

$27.9

+0.13 (+0.5%)· Recorded snapshot

Market cap	2.1B
Revenue (ttm)	1.3B
Net income (ttm)	78.6M
EPS (ttm)	$0.91
Shares out	76.7M
P/E (trailing)	30.7x
P/E (forward)	12.7x
Volume	403,483
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): 78.6M
EPS (ttm): $0.91
P/E (trailing): 30.7x
P/E (forward): 12.7x
Market cap: 2.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	보유

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E12.7

P25 n/aP50 n/aP75 n/a

Trailing P/E30.7

P25 n/aP50 n/aP75 n/a

ROE16.2

P25 n/aP50 n/aP75 n/a

ROIC32.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PGNY indicators

Market & fundamental data

Available fields

266

Groups with data

Currency

USD

Showing 266 of 266 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001551306
Company name	Progyny, Inc.
Country	United States
Country code	US
CUSIP number	74340E103
Earnings date	2026-11-04
Earnings time	amc
Employees	856
Employees change	176
Employees growth	25.88%
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
In index	RUSSELL2000
Industry	Healthcare Plans
IPO date	2019-10-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US74340E1038
Last 10-K release date	2026-02-27
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$27.85
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	PGNY
U.S. state	New York
Website	https://www.progyny.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	14.07x
Average P/E ratio (3Y)	38.97x
Average P/E ratio (5Y)	52.85x
Earnings yield	3.26%
EV/Earnings	24.65x
EV/EBIT	16.18x
EV/EBITDA	15.44x
EV/FCF	10.87x
EV/Sales	1.48x
FCF / EV yield	9.2%
FCF yield	8.3%
Forward EV/Sales	1.35x
Forward P/E	12.71x
Forward P/S	1.49x
Graham number	10.97694
Graham upside	-60.8%
Industry forward P/E	15.1x
Industry P/E	21.51x
Lynch fair value	$4.54
Lynch upside	-83.8%
P/(FCF - SBC) ratio	30.17x
P/(OCF - SBC) ratio	22.84x
P/B ratio	4.7x
P/E ratio	30.7x
P/FCF ratio	12.04x
P/OCF ratio	10.68x
P/S ratio	1.64x
PEG ratio	1.09x
Price / tangible book value	5.02x
Price/EBITDA ratio	17.11x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.14%
EBITDA margin	9.58%
Effective tax rate	34.38%
FCF margin	13.61%
Gross margin	24.57%
Operating margin	9.14%
Pretax margin	9.14%
Profit margin	6%
Profit per employee	$91,861
Profitable quarters	24
Profitable years	6
Revenue per employee	$1.5M
ROA	10.14%
ROA (5Y)	6.12%
ROCE	25.19%
ROE	16.24%
ROE (5Y)	15.6%
ROIC	32.44%
ROIC (5Y)	23.83%
SBC / revenue	8.18%
Tax / revenue	3.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	55.39%
EPS growth (Q)	78.95%
EPS growth (QoQ)	17.24%
EPS growth 3Y	22.78%
EPS growth 5Y	3.09%
EPS growth quarters	5
EPS growth years	1
FCF growth	-6.21%
FCF growth (Q)	-12.01%
FCF growth (QoQ)	11.63%
FCF growth 3Y	2.55%
FCF growth 5Y	66.65%
Gross profit growth	16.09%
Gross profit growth (Q)	13.08%
Gross profit growth 3Y	15.37%
Gross profit growth 5Y	26.35%
Net income growth	48.02%
Net income growth (Q)	63.93%
Net income growth (QoQ)	15.76%
Net income growth 3Y	16.85%
Net income growth 5Y	0.22%
Net income growth quarters	5
Net income growth years	1
OCF growth	-0.37%
OCF growth (Q)	-9.16%
OCF growth (QoQ)	9.74%
OCF growth 3Y	5.91%
OCF growth 5Y	68.25%
Operating income growth	56.08%
Operating income growth (Q)	64.23%
Operating income growth 3Y	38.86%
Operating income growth 5Y	25.32%
Revenue growth	5.54%
Revenue growth (Q)	5.3%
Revenue growth (QoQ)	6.7%
Revenue growth 3Y	11.04%
Revenue growth 5Y	23.84%
Revenue growth quarters	28
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-22.9M
Depreciation and amortization	$5.7M
EBIT	$119.8M
EBITDA	$125.6M
EPS	$0.91
FCF per share	$2.32
Financing cash flow	$-249.8M
Free cash flow	$178.4M
Free cash flow minus SBC	$71.2M
Gross profit	$322.1M
Income taxes	$41.2M
Investing cash flow	$65.7M
Net cash flow	$17.1M
Net income	$78.6M
Operating cash flow minus SBC	$94.1M
Operating income	$119.8M
Revenue	$1.3B
Stock-based compensation	$107.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.63
Book value per share	$5.90
Debt / EBITDA	0.21
Debt / equity	0.06
Debt / FCF	0.15
Goodwill	$19.9M
Long-term assets	$202.8M
Long-term liabilities	$22.5M
Net cash (debt)	$210M
Net cash / market cap	9.77%
Net cash growth	-24.06%
Net debt / EBITDA	-1.67
Net debt / equity	-0.46
Net debt / FCF	-1.18
Piotroski F-Score	6
Property, plant and equipment	$65.6M
Shareholders' equity	$453.3M
Tangible book value	$427.7M
Tangible book value per share	$5.57
Total assets	$715.8M
Total cash	$236.9M
Total debt	$27M
Total liabilities	$262.6M
WACC	9.74%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.78
Current assets	$513M
Current liabilities	$240.1M
Current ratio	2.14
Net working capital	$40.5M
Quick ratio	2.06
Working capital	$272.9M
Working capital turnover	4.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.01%
Dividend yield	0%
Shareholder yield	4.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$25.44
1D price change	0.47%
1M price change	9.47%
1M total return	9.47%
1W price change	-2.55%
1W total return	-2.55%
1Y price change	42.6%
1Y return CAGR	42.64%
1Y total return	42.6%
20-day SMA	$27.47
200-day SMA	$24.33
3M price change	-11.84%
3M total return	-11.84%
3Y price change	-8.66%
3Y return CAGR	-2.97%
3Y total return	-8.66%
50-day SMA	$26.76
50-day SMA vs 200-day SMA	50over200
52-week high	$33.07
52-week high date	2026-07-16
52-week low	$16.10
52-week low date	2026-04-10
5Y price change	-53.89%
5Y return CAGR	-14.35%
5Y total return	-53.89%
6M price change	51.28%
6M total return	51.28%
All-time high	$68.32
All-time high date	2021-11-05
All-time low	$13.29
All-time low date	2019-10-25
Average true range (ATR)	$0.87
Average volume	984.3K
Beta (1Y)	0.22
Beta (2Y)	0.63
Beta (5Y)	1.02
Change from 52-week high	-15.77%
Change from 52-week low	72.98%
Change from all-time high	-59.24%
Change from all-time low	109.56%
Change from open	-0.32%
Day's gap	0.79%
Dollar volume	$11.2M
High price	$28.23
Low price	$27.73
Monthly RSI	53.64
Open price	$27.94
Position in 52-week range	24%
Premarket change	-0.25%
Premarket close	$27.72
Premarket price	$27.65
Premarket volume	2.9K
Previous close	$27.72
Price vs 150-day SMA	9.48%
Price vs 20-day SMA	1.39%
Price vs 200-day SMA	14.47%
Price vs 50-day SMA	4.09%
Relative volume	0.41
Return from IPO open	107.41%
Return from IPO price	115.38%
RSI	53.07
Sharpe ratio	0.85
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	-0.07
Sortino ratio	1.5
Sortino ratio (3Y)	0.25
Sortino ratio (5Y)	0.01
Volume	403.5K
Weekly RSI	55.29
YTD price change	8.45%
YTD total return	8.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70.2M
Float percentage	91.53%
Shares change (QoQ)	-3.08%
Shares change (YoY)	-4.01%
Shares held by insiders	1.81%
Shares held by institutions	102.96%
Shares outstanding	76.7M
Short % of float	7.25%
Short % of shares	6.64%
Short ratio	4.4 days

Deeper analysis on PGNY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PGNY report

Is a complete PGNY research report available?

No complete published report is available for Progyny, Inc. (PGNY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Progyny, Inc. (PGNY)

Price

Financial snapshot

Fair-value bridge

Latest news · PGNY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PGNY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PGNY

Frequently asked questions